Olbert P - Search Results

1

Serum DNA and urine DNA alterations of urinary transitional cell bladder carcinoma detected by fluorescent microsatellite analysis.

von Knobloch R, Hegele A, Brandt H, Olbert P, Heidenreich A, Hofmann R. von Knobloch R, et al. Among authors: olbert p. Int J Cancer. 2001 Oct 1;94(1):67-72. doi: 10.1002/ijc.1434. Int J Cancer. 2001. PMID: 11668480

2

[Transitional cell carcinoma of the bladder. Evaluation of plasma levels of cellular fibronectin as a stage-dependent marker].

Hegele A, Kosche B, Schrader AJ, Sevinc S, Olbert PJ, Hofmann R, Kropf J. Hegele A, et al. Among authors: olbert pj. Urologe A. 2008 Sep;47(9):1137-40. doi: 10.1007/s00120-008-1825-z. Urologe A. 2008. PMID: 18651122 German.

3

Cellular fibronectin in patients with transitional cell carcinoma of the bladder.

Hegele A, Heidenreich A, Varga Z, von Knobloch R, Olbert P, Kropf J, Hofmann R. Hegele A, et al. Among authors: olbert p. Urol Res. 2003 Feb;30(6):363-6. doi: 10.1007/s00240-002-0280-3. Epub 2002 Oct 1. Urol Res. 2003. PMID: 12599015

4

CA19.9 and CEA in transitional cell carcinoma of the bladder: serological and immunohistochemical findings.

Hegele A, Mecklenburg V, Varga Z, Olbert P, Hofmann R, Barth P. Hegele A, et al. Among authors: olbert p. Anticancer Res. 2010 Dec;30(12):5195-200. Anticancer Res. 2010. PMID: 21187512

5

Antineoplastic effect of immunostimulatory DNA (CpG-ODN) in a murine C57-BL6/MB-49 transitional cell carcinoma model.

Hegele A, Dalpke A, Barth P, Varga Z, Heeg K, Hofmann R, Olbert P. Hegele A, et al. Among authors: olbert p. Anticancer Res. 2004 Jul-Aug;24(4):2225-30. Anticancer Res. 2004. PMID: 15330165 Free article.

6

Metastatic non-clear cell renal cell carcinoma: current therapeutic options.

Schrader AJ, Olbert PJ, Hegele A, Varga Z, Hofmann R. Schrader AJ, et al. BJU Int. 2008 Jun;101(11):1343-5. doi: 10.1111/j.1464-410X.2008.07462.x. Epub 2008 Jan 30. BJU Int. 2008. PMID: 18241246 Review.

7

Epithelial mesenchymal transition status is associated with anti-cancer responses towards receptor tyrosine-kinase inhibition by dovitinib in human bladder cancer cells.

Hänze J, Henrici M, Hegele A, Hofmann R, Olbert PJ. Hänze J, et al. BMC Cancer. 2013 Dec 11;13:589. doi: 10.1186/1471-2407-13-589. BMC Cancer. 2013. PMID: 24325461 Free PMC article.

8

[Focus on tumor immunology of transitional cell carcinoma].

Olbert PJ, Schrader AJ, Hegele A, Hofmann R. Olbert PJ, et al. Urologe A. 2007 Sep;46(9):1135-7. doi: 10.1007/s00120-007-1464-9. Urologe A. 2007. PMID: 17605116 German. No abstract available.

9

[Gender-specific characteristics and survival of renal cell carcinoma].

Schrader AJ, Sevinc S, Olbert PJ, Hegele A, Varga Z, Hofmann R. Schrader AJ, et al. Among authors: olbert pj. Urologe A. 2008 Sep;47(9):1182, 1184-6. doi: 10.1007/s00120-008-1832-0. Urologe A. 2008. PMID: 18679648 German.

10

[Immunostimulatory CpG oligodeoxynucleotides (CpG-ODN) in an orthotopic murine transitional cell carcinoma (TCC) model. Effect on local cytokine expression].

Olbert PJ, Schrader AJ, Hofmann R, Hegele A. Olbert PJ, et al. Urologe A. 2008 Sep;47(9):1133-4, 1136. doi: 10.1007/s00120-008-1824-0. Urologe A. 2008. PMID: 18679650 German.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

91 results

Search Page

Filters